Evidence map›Paper›PMID 40832528›Full record

ArticleACS medicinal chemistry letters2025

Discovery of Small-Molecule Ligands for the E3 Ligase STUB1/CHIP from a DNA-Encoded Library Screen.

Simon C C Lucas, Alexander G Milbradt, Jason Breed, Erwin De Genst, Anne Jackson, Alisa Solovyeva, Bryony Ackroyd, Matthias R Bauer, Juntai Liu, David Longmire and 18 more

Abstract read
In one paragraph

Article in ACS medicinal chemistry letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Simon C C LucasHit Discovery, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K.ORCID https://orcid.org/0000-0002-9172-8739
Alexander G MilbradtProtein Science, Structure and Biophysics, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K.
Jason BreedProtein Science, Structure and Biophysics, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K.
Erwin De GenstProtein Science, Structure and Biophysics, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K.
Anne JacksonAssays, Profiling and Cell Sciences, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K.
Alisa SolovyevaHit Discovery, Discovery Sciences, R&D, AstraZeneca, SE-431 83 Gothenburg, Sweden.
Bryony AckroydProtein Science, Structure and Biophysics, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K.
Matthias R BauerHit Discovery, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K.ORCID https://orcid.org/0000-0003-4015-6483
Juntai LiuProtein Science, Structure and Biophysics, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K.
David LongmireMedicinal Chemistry, Oncology, R&D, AstraZeneca, Cambridge CB2 0AA, U.K.
Dušan PetrovićHit Discovery, Discovery Sciences, R&D, AstraZeneca, SE-431 83 Gothenburg, Sweden.ORCID https://orcid.org/0000-0002-1834-7358
Emma L RiversHit Discovery, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K.
Christopher StubbsProtein Science, Structure and Biophysics, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K.
Poppy WinlowAssays, Profiling and Cell Sciences, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K.
Sana BazzazX-Chem Inc., Waltham, Massachusetts 02453, United States.
Paige DicksonX-Chem Inc., Waltham, Massachusetts 02453, United States.ORCID https://orcid.org/0000-0002-9196-2031
Diana GikunjuX-Chem Inc., Waltham, Massachusetts 02453, United States.
Marie-Aude GuiéX-Chem Inc., Waltham, Massachusetts 02453, United States.
John P GuilingerX-Chem Inc., Waltham, Massachusetts 02453, United States.
Christopher D HuppX-Chem Inc., Waltham, Massachusetts 02453, United States.
Rachael JetsonX-Chem Inc., Waltham, Massachusetts 02453, United States.
Anthony D KeefeX-Chem Inc., Waltham, Massachusetts 02453, United States.
Katherine NugaiX-Chem Inc., Waltham, Massachusetts 02453, United States.
John T S YeomanX-Chem Inc., Waltham, Massachusetts 02453, United States.
Ying ZhangX-Chem Inc., Waltham, Massachusetts 02453, United States.
Xian FengPharmaron Beijing Co., Ltd., Beijing 100176, P. R. China.
Dequan YuPharmaron Beijing Co., Ltd., Beijing 100176, P. R. China.
Christopher PhillipsProtein Science, Structure and Biophysics, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

STIP1 homology and U-box containing protein 1 (STUB1), also known as the C-terminus of Hsc70-interacting protein (CHIP), is an E3 ligase that plays a crucial role in removal of misfolded proteins via Hsc70. A DEL screen was run against CHIP to identify small-molecule binders. Two hits were identified that were confirmed by biochemical and biophysical techniques, including 2D NMR. X-ray crystal structures were obtained, which revealed binding to the peptide binding site. Fragment-based deconstruction indicated that hit

Indexed as

ArrayCHIPDELE3 ligasePPIRearrangementSTUB1

Identifiers

PMID40832528
PMCPMC12358985

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.